We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
(+25%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$134M |
| 2 |
Microsoft
MSFT
|
+$119M |
| 3 |
Apple
AAPL
|
+$87.6M |
| 4 |
AbbVie
ABBV
|
+$61.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.9M |
| 2 |
RTN
Raytheon Company
RTN
|
+$71.6M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.9M |
| 5 |
Domino's
DPZ
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Communication Services | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Personalis
PSNL
$1.51B
| $250K | ﹤0.01% |
+19,275
| New | +$214K |
|
2652
SoundThinking
SSTI
$103M
| $250K | ﹤0.01% |
9,907
+245
| +3% | +$6.57K |
|
2653
Anavex Life Sciences
AVXL
$310M
| $249K | ﹤0.01% |
50,512
+17,387
| +52% | +$65.7K |
|
2654
Donegal Group Class A
DGICA
$714M
| $249K | ﹤0.01% |
17,517
-190
| -1% | -$2.71K |
|
2655
KVH Industries
KVHI
$157M
| $249K | ﹤0.01% |
27,905
+2,473
| +10% | +$21.8K |
|
2656
Alico
ALCO
$283M
| $248K | ﹤0.01% |
7,974
+584
| +8% | +$17.4K |
|
2657
Lakeland Industries
LAKE
$119M
| $248K | ﹤0.01% |
+11,070
| New | +$181K |
|
2658
Norwood Financial Corp
NWFL
$368M
| $248K | ﹤0.01% |
9,999
-1,665
| -14% | -$39.5K |
|
2659
Uranium Energy
UEC
$5.57B
| $248K | ﹤0.01% |
282,282
+50,685
| +22% | +$49.1K |
|
|
YARW
2660
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
| $248K | ﹤0.01% |
40
+27
| +208% | +$183K |
|
2661
Western New England Bancorp
WNEB
$275M
| $248K | ﹤0.01% |
42,864
-14,633
| -25% | -$81.1K |
|
|
GCAP
2662
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $248K | ﹤0.01% |
41,165
+3,296
| +9% | +$20.3K |
|
2663
Boston Omaha
BOC
$436M
| $247K | ﹤0.01% |
15,449
+4,370
| +39% | +$72.9K |
|
2664
FS Bancorp
FSBW
$320M
| $247K | ﹤0.01% |
12,790
+1,140
| +10% | +$22.2K |
|
|
GDEN
2665
DELISTED
Golden Entertainment
GDEN
| $246K | ﹤0.01% |
27,527
+1,380
| +5% | +$12.8K |
|
|
SNCR
2666
DELISTED
Synchronoss Technologies
SNCR
| $244K | ﹤0.01% |
7,692
-1,048
| -12% | -$28.9K |
|
|
GRTS
2667
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $244K | ﹤0.01% |
36,816
+6,563
| +22% | +$44.2K |
|
|
TREC
2668
DELISTED
Trecora Resources
TREC
| $244K | ﹤0.01% |
38,900
+3,310
| +9% | +$18.5K |
|
2669
Spero Therapeutics
SPRO
$73M
| $243K | ﹤0.01% |
17,929
+1,512
| +9% | +$17K |
|
|
HTZ
2670
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $243K | ﹤0.01% |
172,680
-13,617
| -7% | -$43.2K |
|
2671
Apyx Medical
APYX
$171M
| $242K | ﹤0.01% |
43,627
+2,785
| +7% | +$11.6K |
|
2672
Accuray
ARAY
$34M
| $242K | ﹤0.01% |
119,098
+4,436
| +4% | +$9.24K |
|
2673
Rocky Brands
RCKY
$369M
| $241K | ﹤0.01% |
11,714
-763
| -6% | -$15.2K |
|
|
GTYH
2674
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
| $239K | ﹤0.01% |
57,414
+5,350
| +10% | +$20.9K |
|
2675
Ardmore Shipping
ASC
$683M
| $238K | ﹤0.01% |
54,880
+4,644
| +9% | +$24.9K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.
- RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
- RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
- RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
- RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
- RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
- RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.
Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.